Targeted inhibition of colorectal cancer proliferation: The dual-modulatory role of 2,4-DTBP on anti-apoptotic Bcl-2 and Survivin proteins.

1 , 2 Recent data from GLOBOCAN 2020 elucidate a worrying trend, placing CRC at the third spot in terms of cancer incidence, encompassing 10% of all new cancer diagnoses, while it stands second in causing 9.4% of global cancer‐related fatalities, irrespective of demographic divisions such as age and gender. 3 The disease exhibits significant variability, in

also in 311 other papers